Seagull BioSolutions specializes in the advancement and commercialization of innovative technologies for medical purposes. They have autonomously created an Indian mammalian expression system known as "The eSAME technology", which is valuable for manufacturing recombinant protein, viral vaccines, and therapeutic agents. The eSAME system can also be modified to produce novel gene therapy agents. Seagull BioSolutions is currently leveraging this adaptable technology platform to create new medical products that cater to critical unmet healthcare needs.